Menu Close

Articles on Drug marketing

Displaying all articles

OxyContin, an opioid drug heavily marketed by Purdue Pharma, is associated with billions of dollars of health-care costs in Canada related to the opioid crisis. (AP Photo/Toby Talbot)

$150M is not enough: Canada’s proposed Purdue Pharma settlement for opioid damages is paltry and won’t prevent future crises

The Purdue Pharma settlement is paltry compared to costs of the opioid crisis. Without major changes to pharma industry regulation, there is little reason to think a similar crisis won’t occur again.
Now you can find out who’s wining and dining our doctors, nurses and pharmacists with publicly available data of drug company funded events. from www.shutterstock.com

Who’s paying for lunch? Here’s exactly how drug companies wine and dine our doctors

Drug companies funded more than 116,000 educational events for doctors over four years. Now you can find out exactly which companies footed the bills and how much they paid.

Top contributors

More